Francisca J.
- Country
- France
- Department
- 1301:Service de Gastroentérologie et assistance nutritive
Research Overview
- Randomized Open-Label Trial Comparing Standard Care Versus Treat-to-Target with Telemonitoring in Ulcerative Colitis Patients Initiating Adalimumab
- Long-Term Safety and Efficacy Evaluation of Glepaglutide in Patients with Short Bowel Syndrome: A Phase 3 Double-Blind Extension Trial
- Long-term Safety and Efficacy Evaluation of Glepaglutide in Adult Patients with Short Bowel Syndrome: A 104-Week Phase 3 Extension Study
Data & Insights
Has run more than one trial at 30 of 68 partner sites.
Specializations
Inflammatory Bowel Disease Management
This investigator specializes in treating ulcerative colitis and Crohn's disease, with particular focus on innovative therapeutic approaches and treatment optimization.
- Fecal Microbiota Transplantation
- Corticosteroid-free Treatment Strategies
- Combination Therapy Approaches
Advanced expertise in biologics administration and therapeutic monitoring using e-health solutions.
Short Bowel Syndrome Care
Dedicated to advancing treatment options for patients with Short Bowel Syndrome and associated intestinal failure conditions.
- Novel Therapeutic Agents
- Long-term Treatment Safety
- Intestinal Failure Management
Specialized focus on emerging treatments including apraglutide and glepaglutide therapies.
Therapeutic Innovation
Explores cutting-edge approaches in gastroenterological treatments with emphasis on patient monitoring and therapeutic optimization.
- Telemonitoring Systems
- Patient Education Programs
- Treatment Response Assessment
Integration of modern monitoring techniques with conventional therapeutic approaches.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.